Correction: Suppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatin

Oncotarget. 2024 Oct 1:15:697-698. doi: 10.18632/oncotarget.28657.
No abstract available

Publication types

  • Published Erratum

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Cisplatin* / pharmacology
  • Cisplatin* / therapeutic use
  • Drug Resistance, Neoplasm
  • Gene Expression Regulation, Neoplastic / drug effects
  • Humans
  • Intercellular Signaling Peptides and Proteins* / metabolism
  • Progranulins* / metabolism
  • Urinary Bladder Neoplasms* / drug therapy
  • Urinary Bladder Neoplasms* / genetics
  • Urinary Bladder Neoplasms* / metabolism
  • Urinary Bladder Neoplasms* / pathology

Substances

  • Progranulins
  • Cisplatin
  • Intercellular Signaling Peptides and Proteins
  • GRN protein, human
  • Antineoplastic Agents